Nasdaq-Listed Windtree Therapeutics Commits $520M to BNB: A Bold Crypto Move
Discover how Windtree Therapeutics, a Nasdaq-listed biotech firm, is investing $520M in BNB cryptocurrency, signaling a bold pivot to digital assets. Learn the details and implications!